Our Provider Databases
Medical imaging saves millions of lives each year, helping doctors to detect and diagnose a wide range of diseases, from cancer and appendicitis to stroke and heart disease.
Because non-invasive early disease detection saves so many lives, scientific investment continues to increase. Let’s take a look at 2019’s biggest up-and-coming medical imaging technology trends:
Artificial intelligence in the medical imaging market is estimated to rise from $21.48 billion in 2018 to a projected value of $264.85 billion by 2026, according to Data Bridge Market Research’s April 2019 report. With hundreds of AI technology solutions being developed for the medical imaging market, these vendors will need to prove their ROI in a very competitive, and crowded, setting.
AI has the potential to revolutionize the medical imaging industry by sifting through mountains of scans quickly and offering providers and patients with life-changing insights into a variety of diseases, injuries, and conditions that may be hard to detect without the supplemental technology. Take these integrations, for example:
Right now, the world can’t get enough of virtual reality (VR). Oculus Rift virtual reality goggles are a best seller on Amazon and there are even virtual reality arcades popping up in shopping malls that allow customers to feel the sensation of being “virtually” chased by zombies.
VR and 3D imaging technologies are not only great for entertainment, but they also have important implications within the medical imaging industry. As amazing as MRIs and CT scans are, currently, their display in 2D requires physicians to use their imaginations to mentally stitch together a full picture of the 3D organ or body part. Now, new augmented reality technologies, like EchoPixel True 3D, have made it possible for radiologists or physicians to take slices of MRI pictures to create a 3D image that physicians can examine with 3D glasses, a VR headset, or even print using a 3D printer and special plastic.
With nuclear imaging, a patient is injected with or swallows radioactive materials called radiotracers or radiopharmaceuticals prior to a medical imaging scan like a position emission tomography (PET) and/or a single-photon emission computed tomography (SPECT). During the scan, the camera focuses on the area where the radioactive material concentrates, showing the doctor what kind of problem exists. These types of scans are particularly helpful when diagnosing thyroid disease, gall bladder disease, heart conditions, cancer, and Alzheimer’s disease. Currently, there are many exciting developments in this area; to name a few:
Wearable medical devices are not only a top healthcare trend this year, but they are also slated to revolutionize diagnostic imaging in 2019 as well. Two notable devices include:
With data on approximately 14,600 hospital-based, freestanding, and portable imaging centers across the U.S., Definitive Healthcare can help you:
Fig 1: A quick (not fully-comprehensive) look at some of the Definitive Healthcare’s imaging center search functionality
Looking to learn more about selling to physicians in an outpatient setting? Join us for our live webinar, Selling to Doctors in the Fast-Growing Outpatient Market, on May 1st at 2pm EST.
In this webinar, Enterprise Account Executive Maggie Fortune will cover how:
Save your seat today!